ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0300

Salivary Gland Epithelial Cells Transcriptomic Analysis Highlight Their Potential Involvement in Extracellular Matrix Modification in Sjögren’s Syndrome

Elodie Rivière1, Juliette Pascaud1, Franck Letourneur2, Gaetane Nocturne1 and Xavier Mariette3, 1Immunology of viral Infections and Autoimmune Diseases, IDMIT, CEA - Université Paris Sud - INSERM U1184 ; Rheumatology, APHP, Université Paris Saclay, Le Kremlin Bicêtre, France, 2Plateforme Génomique : GENOM'IC — Institut Cochin, Paris, France, 3Université Paris- Saclay, Rheumatology, Paris, France

Meeting: ACR Convergence 2021

Keywords: Gene Expression, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Sjögren's Syndrome – Basic & Clinical Science Poster (0296–0322)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Salivary gland epithelial cells (SGECs) participate to the hyper activation of the immune system in primary Sjögren’s syndrome (pSS). This study aimed to analyze the transcriptomic characteristics of primary cultured SGECs from pSS patients compared to controls, in order to identify pathways involved in pSS pathogenesis.

Methods: Minor salivary gland (MSG) biopsies were obtained from patients referred for suspicion of pSS. pSS was defined according to the 2016 ACR/EULAR criteria. Controls had sicca symptoms without anti-SSA/SSB and with normal MSG. Primary cultures of SGECs were established from MSGs. After 2 to 3 weeks of culture, cells were dissociated and incubated at 37°C for 24h. Total RNA was extracted and reverse-transcribed. Libraries were sequenced on Illumina Nextseq 500. Statistical analyses of the RNA-Seq used DESeq2 package. Absolute FC value >1.5 and p-value< 0.05 was applied to identify up and down-regulated genes.

Results: Patient’s characteristics are presented in Table 1. The comparison of gene expression in primary cultured SGECs of pSS compared to controls showed 511 differentially expressed genes: 251 upregulated and 260 downregulated. Functional enrichment pathway analysis highlighted an over-representation of the Inhibition of Matrix Metalloproteases signaling pathway (Table 2). Among the most upregulated genes, we identified genes involved in extracellular matrix formation, including several collagen genes: COL3A1 and COL1A2 with the higher fold-change (FC) (log2FC = 2.40, log2FC = 2.12, respectively). There were also several ADAMDTS genes (A Disintegrin and Metalloproteinases with a Thrombospondin motif) related genes such as ADAMTS2, ADAMTS16, ADAMTS12 (log2FC = 2.09, log2FC = 1.57, log2FC =1.31, respectively). Other genes that might have a role in saliva secretion such as CFTR and AQP6 were differentially expressed. CFTR, which codes for a channel that conducts chloride ions across epithelial membranes, was upregulated (log2FC=1.67), whereas AQP6 was downregulated (log2FC=-1.44). There was an upregulation of HLA-C (log2FC=0.63), as well as CCR7 (log2FC=1.26). Lastly, we identified an upregulation of the androgen receptor (AR) gene (log2FC=1.71). A schematic representation of these results is presented in Figure 1.

Conclusion: Differentially expressed genes between pSS and controls SGECs included genes involved in the extracellular matrix formation. This result suggests a role for SGECs in salivary gland fibrosis development. We also observed a downregulation of AQP6. A potential role of AQP5 abnormal localization on saliva secretion in pSS has already been described, however, AQP6 potential involvement in pSS pathophysiology has, to our knowledge, never been described. CFTR upregulation in SGECs from pSS compared to controls could be reactive to the salivary gland damage and dysfunction. The differentially expressed genes identified in this RNA-seq analysis need to be confirmed by qPCR.

These results open the perspective of new potential pathogenic pathways involved in pSS, suggesting the involvement of SGECs in extracellular matrix and fibrosis constitution.

Table 1: Characteristics of the patients included in the study

Table 2: Enrichment pathway analysis of primary cultured SGECs from pSS compared to controls in different conditions of stimulation. Selection of the 10 most significant pathways.

Figure 1: Schematic representation of the differentially expressed genes between pSS and controls in primary cultured SGECs


Disclosures: E. Rivière, None; J. Pascaud, None; F. Letourneur, None; G. Nocturne, None; X. Mariette, GlaxoSmithKline, 2, BMS, 2, Servier, 2, Janssen, 2, Novartis, 2, Pfizer, 2, UCB, 2.

To cite this abstract in AMA style:

Rivière E, Pascaud J, Letourneur F, Nocturne G, Mariette X. Salivary Gland Epithelial Cells Transcriptomic Analysis Highlight Their Potential Involvement in Extracellular Matrix Modification in Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/salivary-gland-epithelial-cells-transcriptomic-analysis-highlight-their-potential-involvement-in-extracellular-matrix-modification-in-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/salivary-gland-epithelial-cells-transcriptomic-analysis-highlight-their-potential-involvement-in-extracellular-matrix-modification-in-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology